These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines. Rosen MJ Chest; 2006 Jan; 129(1 Suppl):122S-131S. PubMed ID: 16428701 [TBL] [Abstract][Full Text] [Related]
63. Non Cystic Fibrosis Bronchiectasis. Gupta AK; Lodha R; Kabra SK Indian J Pediatr; 2015 Oct; 82(10):938-44. PubMed ID: 26307756 [TBL] [Abstract][Full Text] [Related]
64. [Chinese expert consensus on the management of lower respiratory tract infections of Pulmonary Infection Assembly of Chinese Thoracic Society Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):739-752. PubMed ID: 35927044 [TBL] [Abstract][Full Text] [Related]
65. Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture. McShane PJ; Naureckas ET; Strek ME Chest; 2012 Jul; 142(1):159-167. PubMed ID: 22267679 [TBL] [Abstract][Full Text] [Related]
66. [New and Current Concepts of Therapy in Non-CF Bronchiectasis]. Allewelt M; de Roux A Dtsch Med Wochenschr; 2016 May; 141(10):694-9. PubMed ID: 27176062 [TBL] [Abstract][Full Text] [Related]
67. Bronchiectasis. Subhas E; Rees M Aust J Gen Pract; 2022 Dec; 51(12):945-949. PubMed ID: 36451317 [TBL] [Abstract][Full Text] [Related]
68. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection. VanDevanter DR; Gonda I; Dahms J; Cipolla D; Davis AM; Chalmers JD; Froehlich J Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017 [TBL] [Abstract][Full Text] [Related]
69. Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention. Choi H; Chalmers JD Ann Transl Med; 2023 Jan; 11(1):25. PubMed ID: 36760239 [TBL] [Abstract][Full Text] [Related]
70. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis. Chorepsima S; Kechagias KS; Kalimeris G; Triarides NA; Falagas ME Drug Des Devel Ther; 2018; 12():4059-4066. PubMed ID: 30568427 [TBL] [Abstract][Full Text] [Related]
71. Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use. Goldman N; Loebinger MR; Wilson R Expert Rev Respir Med; 2016 Dec; 10(12):1259-1268. PubMed ID: 27820964 [TBL] [Abstract][Full Text] [Related]
72. [Treatment of bronchiectasias]. Purokivi M; Koskela H; Kaarteenaho R Duodecim; 2014; 130(8):769-77. PubMed ID: 24822326 [TBL] [Abstract][Full Text] [Related]
73. Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016. Huang HY; Chung FT; Lo CY; Lin HC; Huang YT; Yeh CH; Lin CW; Huang YC; Wang CH BMC Pulm Med; 2020 Feb; 20(1):45. PubMed ID: 32070324 [TBL] [Abstract][Full Text] [Related]
74. The Pathogenesis of Bronchiectasis. Metersky ML; Barker AF Clin Chest Med; 2022 Mar; 43(1):35-46. PubMed ID: 35236559 [TBL] [Abstract][Full Text] [Related]
75. New therapies for the prevention and treatment of exacerbations of bronchiectasis. Abo-Leyah H; Chalmers JD Curr Opin Pulm Med; 2017 May; 23(3):218-224. PubMed ID: 28212153 [TBL] [Abstract][Full Text] [Related]
76. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Bilton D; Henig N; Morrissey B; Gotfried M Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030 [TBL] [Abstract][Full Text] [Related]